Author

F. Singer

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Organism:human· 2 Assay:bulk RNA-seq· 1 Research Focus:cell signaling & trafficking· 1 Research Focus:clustering· 1 Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1 Research Focus:gene regulatory network inference· 1

Frequent Co-Authors

F. Jacob· 2 shared R. Coelho· 2 shared V. Heinzelmann-Schwarz· 2 shared A. Bertolini· 1 shared A. Dondi· 1 shared A. Fedier· 1 shared B. Bodenmiller· 1 shared B. Seashore-Ludlow· 1 shared

Activity by Year

2022-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 35 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

F. Jacob

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

SMAC mimetics overcome apoptotic resistance in ovarian cancer through MSLN-TNF alpha axis

R. Coelho, B. Seashore-Ludlow, S. Schutz, F. Christopher Lombardo, E. Moussaud-Lamodiere, R. Casanova, J. Ficek-Pascual, K. Brunhilde Labrosse, M. Hensle, M. Lopez-Nunez, N. Rimmer, A. Fedier, R. Lima, C. Montavon Sartorius, C. Kurzeder, , F. Jacob

This study shows SMAC mimetics overcome apoptotic resistance in ovarian cancer by targeting the MSLN-TNF alpha axis, enhancing cell death and synergizing with chemotherapy.

bioRxiv · Jan 24, 2024 · PreprintCancer Biology

Detection of isoforms and genomic alterations by high-throughput full-length single-cell RNA sequencing in ovarian cancer

A. Dondi, U. Lischetti, F. Jacob, F. Singer, N. Borgsmueller, R. Coelho, Tumor Profiler Consortium, V. Heinzelmann-Schwarz, C. Beisel, N. Beerenwinkel

This study uses long-read single-cell RNA sequencing to detect isoforms and genomic alterations in ovarian cancer, revealing novel isoforms, cell type-specific expression patterns, and gene fusions.

bioRxiv · Dec 12, 2022Cancer Biology